Search research articles
Contact Us
Filters
Showing results (251-260 of 257) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 257 results.
The Pediatric Infectious Disease Journal
|
April 20, 2016
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure
Christopher R Cannavino, Rodrigo E Mendes, Helio S Sader, et al.
The Journal of Infectious Diseases
|
October 10, 2014
Cytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
Hannah R Rose, Robert S Holzman, Deena R Altman, et al.
Diagnostic Microbiology and Infectious Disease
|
September 20, 2020
In vitro activity of KHP-3757 (a novel LpxC inhibitor) and comparator agents against recent and molecularly characterized Pseudomonas aeruginosa isolates from a global surveillance program (2017-2018)
Michael D Huband, Jill M Lindley, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
September 18, 2013
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane
Brian Vanscoy, Rodrigo E Mendes, Jennifer McCauley, et al.
Antimicrobial Agents and Chemotherapy
|
February 20, 2020
<i>In Vitro</i> Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates
Michael D Huband, Rodrigo E Mendes, Michael A Pfaller, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model
Brian VanScoy, Rodrigo E Mendes, Anthony M Nicasio, et al.
Antimicrobial Agents and Chemotherapy
|
January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model
Anthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 257) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 257 results.
The Pediatric Infectious Disease Journal
|
April 20, 2016
Evolution of Ceftaroline-Resistant Mrsa in a Child with Cystic Fibrosis Following Repeated Antibiotic Exposure
Christopher R Cannavino, Rodrigo E Mendes, Helio S Sader, et al.
The Journal of Infectious Diseases
|
October 10, 2014
Cytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus
Hannah R Rose, Robert S Holzman, Deena R Altman, et al.
Diagnostic Microbiology and Infectious Disease
|
September 20, 2020
In vitro activity of KHP-3757 (a novel LpxC inhibitor) and comparator agents against recent and molecularly characterized Pseudomonas aeruginosa isolates from a global surveillance program (2017-2018)
Michael D Huband, Jill M Lindley, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
September 18, 2013
Pharmacological basis of β-lactamase inhibitor therapeutics: tazobactam in combination with Ceftolozane
Brian Vanscoy, Rodrigo E Mendes, Jennifer McCauley, et al.
Antimicrobial Agents and Chemotherapy
|
February 20, 2020
<i>In Vitro</i> Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates
Michael D Huband, Rodrigo E Mendes, Michael A Pfaller, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model
Brian VanScoy, Rodrigo E Mendes, Anthony M Nicasio, et al.
Antimicrobial Agents and Chemotherapy
|
January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model
Anthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
Page
of 26